|134.09||-1.59||-1.17%||Vol 187.70K||1Y Perf 85.63%|
|Apr 9th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||129.25||Analyst Rating||Moderate Buy 2.00|
|Potential %||-3.61||Finscreener Ranking||☆ 35.45|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||☆ 34.45|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★ 43.99|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||+ 26.99|
|Market Cap||3.88B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||97.08||Earnings Date||28th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||28th Apr 2021|
|Estimated EPS Next Report||0.43|
|EPS Growth Next 5 Years %||9.90|
|Avg. Weekly Volume||276.38K|
|Avg. Monthly Volume||268.56K|
|Avg. Quarterly Volume||268.79K|
Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 134.09 per share at the end of the most recent trading day (a -1.17% change compared to the prior day closing price) with a volume of 187.74K shares and market capitalization of 3.88B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.
The one-year performance of Conmed Corp. - Ordinary Shares stock is 85.63%, while year-to-date (YTD) performance is 19.72%. CNMD stock has a five-year performance of 226.46%. Its 52-week range is between 60.65 and 136.3, which gives CNMD stock a 52-week price range ratio of 97.08%
Conmed Corp. - Ordinary Shares currently has a PE ratio of 435.30, a price-to-book (PB) ratio of 5.33, a price-to-sale (PS) ratio of 5.85, a price to cashflow ratio of 59.60, a PEG ratio of 2.32, a ROA of 0.52%, a ROC of 2.16% and a ROE of 1.28%. The company’s profit margin is 0.47%, its EBITDA margin is 13.70%, and its revenue ttm is $648.45 Million , which makes it $22.40 revenue per share.
Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.43 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is 28th Apr 2021.
The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (2), with a target price of $129.25, which is -3.61% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Conmed Corp. - Ordinary Shares has a dividend yield of 0.61% with a dividend per share of $0.80 and a payout ratio of 70.00%.
Conmed Corp. - Ordinary Shares has a Buy technical analysis rating based on Technical Indicators (ADX : 9.29, ATR14 : 4.98, CCI20 : 78.70, Chaikin Money Flow : 0.10, MACD : 1.66, Money Flow Index : 61.29, ROC : -0.08, RSI : 56.77, STOCH (14,3) : 59.10, STOCH RSI : 0.90, UO : 53.62, Williams %R : -40.90), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $0), Brian P. Concannon (Sold 3 036 shares of value $271 145 ), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-10 844 640 ), Curt R. Hartman (Sold 35 000 shares of value $3 858 870 ), Daniel S. Jonas (Option Excercise at a value of $1 071 334), Daniel S. Jonas (Sold 21 073 shares of value $2 175 558 ), David M. Bronson (Option Excercise at a value of $0), Heather L. Cohen (Option Excercise at a value of $353 340), Jerome J. Lande (Option Excercise at a value of $0), John E. Kennedy (Option Excercise at a value of $2 260 760), John E. Kennedy (Sold 37 658 shares of value $3 571 271 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Option Excercise at a value of $1 302 481), Johonna Pelletier (Sold 26 056 shares of value $2 943 928 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $387 777), Mark E. Tryniski (Sold 8 265 shares of value $1 004 863 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Peter K. Shagory (Sold 0 shares of value $-353 129 ), Peter K. Shagory (Sold 8 640 shares of value $736 173 ), Stanley W. Peters (Sold 0 shares of value $-637 920 ), Stanley W. Peters (Sold 16 500 shares of value $1 636 250 ), Terence M. Berge (Option Excercise at a value of $2 583 877), Terence M. Berge (Sold 66 458 shares of value $7 065 760 ), Todd W. Garner (Option Excercise at a value of $0), Wilfredo Ruiz-Caban (Sold 0 shares of value $-1 686 103 ), Wilfredo Ruiz-Caban (Sold 9 919 shares of value $813 556 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.